Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mTOR signaling and Alzheimer's disease: What we know and where we are?
Samin Davoody, Afsaneh Asgari Taei, Pariya Khodabakhsh, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 16

Showing 16 citing articles:

GSK3: A potential target and pending issues for treatment of Alzheimer's disease
Jiahui Zhao, Mengying Wei, Min‐Song Guo, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 13
Posterior cingulate cortex microRNA dysregulation differentiates cognitive resilience, mild cognitive impairment, and Alzheimer's disease
Scott Counts, John S. Beck, Bryan Maloney, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access | Times Cited: 1
The role of PI3K signaling pathway in Alzheimer’s disease
Jingying Pan, Yao Qi, Yankai Wang, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 7
Pharmacological mTOR inhibitors in ameliorating Alzheimer’s disease: current review and perspectives
Pei-Lun Xie, Meng-Yu Zheng, Ran Han, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
The potential link between the development of Alzheimer’s disease and osteoporosis
Fariha Nasme, Jyotirmaya Behera, Prisha Tyagi, et al.
Biogerontology (2025) Vol. 26, Iss. 1
Closed Access
Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer’s disease in type 2 diabetes
Prakash Ramakrishan, Jayaraman Rajangam, Shaheedha Shabudeen Mahinoor, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Shared early molecular mechanisms revealed in P301S and 5xFAD Alzheimer’s disease mouse models
Huda Suloh, Shashank Kumar Ojha, Maryam Kartawy, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Berbamine Targets the FKBP12-Rapamycin-Binding (FRB) Domain of the mTOR Complex to Promote Microglial Autophagy and Ameliorate Neuroinflammation in Alzheimer’s Disease
Pingyuan Ge, Siqi Guo, Pingping Wang, et al.
Phytomedicine (2025) Vol. 142, pp. 156771-156771
Closed Access
Patterns of phosphorylated tau accumulation in a spectrum of acquired and developmental brain lesions associated with refractory epilepsy
Alicja Mrzyglod, Anya Mebrouk, Joanna Bartkiewicz, et al.
Epilepsia (2025)
Open Access
Inborn errors of canonical autophagy in neurodegenerative diseases
Dennis Freisem, Helene Hoenigsperger, Alberto Catanese, et al.
Human Molecular Genetics (2025)
Open Access
Phytotherapy in Alzheimer’s Disease—A Narrative Review
Julia Piekarz, Natalia Picheta, Oliwia Burdan, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1812-1812
Open Access | Times Cited: 2
Brain Insulin Resistance in Down Syndrome: Involvement of PI3K-Akt/mTor Axis in Early-Onset of Alzheimer's Disease and Its Potential as A Therapeutic Target
Mansour Azimzadeh, Pike-See Cheah, King‐Hwa Ling
Biochemical and Biophysical Research Communications (2024) Vol. 733, pp. 150713-150713
Closed Access | Times Cited: 2
miRNA375-3p/rapamycin mediates the mTOR pathway by decreasing PS1, enhances microglial cell activity to regulate autophagy in Alzheimer's disease
Yuxiang Wang, Zixuan Xiao, Hanlan Yin, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e37589-e37589
Open Access | Times Cited: 2
Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
Weilin Shao, Yan Feng, Jin Huang, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
The mTOR Pathway: A Common Link Between Alzheimer’s Disease and Down Syndrome
Abigail J. Wohlfert, Jeremiah Phares, Ann‐Charlotte Granholm
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6183-6183
Open Access | Times Cited: 1
FAAH Inhibition Counteracts Neuroinflammation via Autophagy Recovery in AD Models
Federica Armeli, Roberto Coccurello, Giacomo Giacovazzo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12044-12044
Open Access | Times Cited: 1
LRRC25 expression during physiological aging and in mouse models of Alzheimer’s disease and iPSC-derived neurons
Dinesh Devadoss, Juliet Akkaoui, Madhavan Nair, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access
Page 1

Scroll to top